Innovex International, Inc.(US:INVX)2024-11-08 21:01Financial Performance - For the nine months ended September 30, 2024, Innovex reported net income, income from operations, and Adjusted EBITDA as approximately 26%, 5%, and 22% of revenue, respectively, with income from operations amounting to $22.2 million[98]. - Revenues for the three months ended September 30, 2024, were $151.8 million, a 9% increase from $139.1 million in the same period of 2023[118]. - Net income for the three months ended September 30, 2024, was $82.6 million, a 437% increase from $15.4 million for the same period in 2023[131]. - Net income for the nine months ended September 30, 2024, was $108.5 million, an increase of $53.0 million, or 95%, from $55.5 million for the same period in 2023[144]. - Adjusted EBITDA for the nine months ended September 30, 2024, was $89.4 million, down 12% from $101.1 million in the same period in 2023[164]. - The company’s net income as a percentage of revenue increased to 54% for the three months ended September 30, 2024, compared to 11% in the same period in 2023[164]. - The company’s Adjusted EBITDA Margin decreased to 18% for the three months ended September 30, 2024, from 24% in the same period in 2023[164]. Revenue Breakdown - The North America market accounted for approximately 63% of total revenue, while international and offshore markets contributed 37%[94]. - Innovex aims to significantly increase revenue from international and offshore markets, particularly in the Middle East, which has become the largest market for the company[94]. - NAM market revenue for the nine months ended September 30, 2024, was $258.3 million, a decrease of $22.5 million from $280.8 million in the same period of 2023[131]. - International and Offshore market revenue for the nine months ended September 30, 2024, was $151.8 million, an increase of $10.2 million from $141.6 million in the same period of 2023[131]. Costs and Expenses - Cost of revenues for the three months ended September 30, 2024, was $99.1 million, an 11% increase from $89.2 million for the same period in 2023[120]. - Selling, general and administrative expenses for the three months ended September 30, 2024, were $38.0 million, a 98% increase from $19.2 million in the same period of 2023[121]. - Total costs and expenses for the three months ended September 30, 2024, were $165.0 million, a 43% increase from $115.1 million in the same period of 2023[118]. - Total depreciation and amortization expense for the nine months ended September 30, 2024, was $19.2 million, an increase of $2.6 million from $16.6 million for the same period in 2023[136]. Acquisition and Merger - The company has a disciplined acquisition strategy and has identified numerous high-quality acquisition targets to enhance growth[96]. - Innovex's merger with Legacy Innovex was completed on September 6, 2024, with the new company name being Innovex International, Inc.[100]. - Acquisition costs for the three months ended September 30, 2024, were $20.3 million, a significant increase from $0.8 million in the same period of 2023[125]. - Acquisition costs for the nine months ended September 30, 2024, were $25.5 million, an increase of $23.5 million from $2.0 million for the same period in 2023, primarily due to the Merger[138]. - Gain on bargain purchase for the three months ended September 30, 2024, was $92.7 million, compared to zero in the same period of 2023[129]. - Gain on bargain purchase for the nine months ended September 30, 2024, was $92.7 million, compared to zero for the same period in 2023, related to the Merger[142]. Cash Flow and Financial Position - Cash provided by operating activities was $57.1 million for the nine months ended September 30, 2024, compared to $54.5 million for the same period in 2023, reflecting a $2.6 million increase[149]. - Net cash provided by investing activities was $150.4 million for the nine months ended September 30, 2024, compared to $(31.6) million for the same period in 2023, a $182.0 million increase[151]. - As of September 30, 2024, the company had cash and restricted cash of $99.9 million and availability under the Revolver of $90.8 million[145]. - As of September 30, 2024, the company had $12.7 million in borrowings under the Term Loan and $31.3 million under the Revolver, compared to $19.0 million and $31.3 million, respectively, as of September 30, 2023[159]. Debt and Interest - The effective interest rate on the term loan was approximately 8.85% for the nine months ended September 30, 2024, compared to 7.33% for the same period in 2023[147]. - Total interest expense, net for the nine months ended September 30, 2024, was $2.1 million, a decrease of $2.6 million from $4.7 million for the same period in 2023[139]. - The company maintained a total leverage ratio of not more than 2.50 to 1.00 as of the last day of each fiscal quarter, in compliance with the Credit Facility[158]. Risk Management - The company is exposed to commodity price risk due to fluctuations in oil and natural gas prices, which can impact drilling and completion activity levels of its customers[181]. - Legacy Innovex does not currently intend to hedge its indirect exposure to commodity price risk[181]. - The company does not currently intend to hedge its exposure to interest rate risk[182]. - Credit risk is managed by analyzing the financial condition of counterparties prior to accepting new customers and adjusting existing credit limits[183]. - The estimates and assumptions used in impairment assessments are considered reasonable, but significant market changes could lead to future impairments[178]. Impairment and Valuation - The company evaluates property and equipment for impairment whenever changes in circumstances indicate that the carrying amount may not be recoverable[176]. - An annual impairment analysis of goodwill is performed as of December 31st or whenever a triggering event occurs[176]. - The company utilizes independent valuation specialists to assist in determining the fair value of acquired assets during significant acquisitions[175]. - In Q2 2024, Legacy Innovex recognized total impairment losses of $3.0 million for an operating lease right of use asset and $0.5 million for a company-owned building due to a significant decrease in fair value[177]. - The valuation allowance for deferred tax assets was $65.1 million as of September 30, 2024[173].